AsianScientist (Mar. 21, 2014) – Scientists have created at least five new experimental substances based on a tiny protein found in cone snail venom that could someday lead to the development of safe and effective oral medications for treatment of chronic nerve pain.
“This is an important incremental step that could serve as the blueprint for the development of a whole new class of drugs capable of relieving one of the most severe forms of chronic pain that is currently very difficult to treat,” said Dr David Craik from the University of Queensland, who led the study.
Acute pain occurs when the nervous system is stimulated by a wound or injury and naturally subsides over time. In contrast, chronic neuropathic pain kicks in when the nervous system itself is damaged. This type of pain — which is often triggered by diabetes, multiple sclerosis and other diseases — can last for months, years or even decades. Current treatments for chronic neuropathic pain have serious side effects and provide relief to only about one in every three patients.
One possible solution that Craik and his colleagues are investigating comes from an unlikely source, the cone snail. Cone snails are marine animals that use venom to paralyze their prey. This venom contains hundreds of peptides (small proteins) known as conotoxins.
In humans, some of these conotoxins appear to have analgesic effects. So far, however, only one conotoxin-derived medication has been approved for human use. This drug, ziconotide, has one big drawback: It has to be infused directly into the lower part of the spinal cord — a clearly invasive procedure.
The team is working to develop a conotoxin-based drug that can be taken orally, which would be much more practical for patients. In previous research, they found a way to modify conotoxin peptides so they formed circular chains of amino acids. The modified peptides are extremely stable and resistant to enzymes in the body.
In laboratory rats, a single, small oral dose of a prototype drug based on one of these looped conotoxins appeared to significantly reduce pain. The scientists found that this prototype drug was about 100 times more potent than morphine or gabapentin, the two drugs that are considered the “gold standard” treatments for chronic nerve pain.
Furthermore, addiction is less of a concern because conotoxins act on different receptors in the brain than morphine and other opiate drugs.
“We don’t know about side effects yet, as it hasn’t been tested in humans. But we think it would be safe,” Craik said. “It acts by a completely different mechanism than morphine so we think it has a minimal possibility of producing the side effects of that medication. That is one of the big advantages of this drug.”
Craik’s team also has developed at least five additional new substances based on the looped conotoxin prototype drug. They are currently evaluating the therapeutic potential of these new substances, which they developed by tweaking the composition of the amino acids in the prototype conotoxin drug used in their initial animal studies. They are also seeking funding and approval for human studies.
——
Source: University of Queensland; Photo: OurBreathingPlanet/Flickr/CC.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
